Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04575714
Other study ID # PO19084
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 19, 2019
Est. completion date November 19, 2019

Study information

Verified date September 2020
Source CHU de Reims
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In France the prevalence of low back pain is 70 to 80 %. It's the leading cause of health expenditure in Europe and costs 900 million euros per year to health insurance in France. This is the second reason to consult a general practitioner. Acute low back pain is defined as low back pain lasts less than 6 weeks. It represents 60 to 70 % of low back pain but only 20% of the costs induced by low back pain in general. In fact, acute low back pain often heals spontaneously.

Risk factors for acute low back pain and risk factors for chronic low back pain have been the subject of many publications. They remain very difficult to prevent in practice because of their multiplicity. Preventing acute low back pain is part of the prevention of chronic low back pain. Patient care management of low back pain is well codified and consensual in the various international recommendations. However, their application is sometimes very disparate and bad habits on both patients and professionals persist. Advices recommended in the case of low back pain are widely disseminated but their applications are little studied. In 2017, in France, health insurance started a "back pain" prevention campaign with the objective of raising awareness of good attitudes in the event of back pain. It made an initial assessment of the different knowledges concerning spinal pain in the general population but also in the medical population with the aim of improving them. It appears that number of patients would not consult physician in this case. The many proposals of care and the diversity of medical professionals, paramedics and other stakeholders, proposing to cure low back pain form as many different clinical pathways. Use of alternative or unconventional medicines is poorly assessed. In this context, it seems relevant to evaluate patient clinical pathways and patients' attitudes.


Description:

The aim of the study is to explore patient clinical pathways and patients' attitudes in acute low back pain


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date November 19, 2019
Est. primary completion date November 19, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility inclusion criteria :

- men and women

- aged between 18 and 65 years old

- living in France

- to have ever had an acute low back pain

- accepting to participate in the study

exclusion criteria :

- over 65 or under 18 years old

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Data record
Data record

Locations

Country Name City State
France Damien JOLLY Reims

Sponsors (1)

Lead Sponsor Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary clinical pathways First professional consulted by patients : general practitioner or specialist Day 0
Secondary patients' attitude patient's first attitude: stop or continue physical activity Day 0
See also
  Status Clinical Trial Phase
Completed NCT00343057 - DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP) N/A
Completed NCT00010985 - Usual Care Vs Choice of Alternative Rx: Low Back Pain Phase 3
Completed NCT00000418 - Psychosocial Treatment for Acute Low Back Pain Phase 2
Completed NCT06022484 - Magnetic Resonance Imaging and Acute Low Back Pain
Completed NCT01708915 - Nonivamide/Nicoboxil Ointment in Acute Low Back Pain Phase 3
Completed NCT00782925 - An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers N/A
Completed NCT04968158 - Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain Phase 3
Completed NCT05001555 - Efficacy and Safety of Dexketoprofen/Vitamin B vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II Phase 3
Completed NCT03424707 - A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain Phase 2
Recruiting NCT04328428 - The Evaluation of Single Acupoint Therapy to Acute Low Back Pain N/A
Completed NCT00643383 - A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain Phase 3
Completed NCT02517762 - Acute Low Back Pain: Causes, Mechanisms, Treatment and Followup N/A
Completed NCT04772781 - Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain Phase 2
Completed NCT00706043 - French Validation Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) Questionnaire
Completed NCT00525811 - Development of a Web-Based Interactive Patient Decision Aid for the Treatment of Acute Low Back Pain and Depression N/A
Completed NCT03341832 - Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain Phase 2
Completed NCT00952068 - A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day Phase 2
Completed NCT04082975 - Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain Phase 3
Recruiting NCT02037763 - A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain N/A
Completed NCT01638286 - Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects N/A